Skip to main content
. 2008 Jul 14;14(26):4156–4167. doi: 10.3748/wjg.14.4156

Figure 2.

Figure 2

Kaplan Meier survival analyses of colorectal cancer subgroups in relation to baseline disease characteristics and EGFR, VEGF-C or VEGF-D expression. A-C: Survival analysis for all patients in relation to UICC stage (P < 0.001), the number of metastases (P < 0.001) and EGFR staining (P = 0.546), respectively; D and E: The 3 years survival in patients with lymph node metastasis in relation, respectively, to the expression of VEGF-C (P = 0.967) and VEGF-D (P = 0.067).